tirzepatide in osa SURMOUNTs obstructive sleep apnea, what's next advancing GLP-1s? Zepbound - Available at Chicago

[DOI] [PubMed] [Google Scholar] 696.Esposito K, Maiorino MI, Di Palo C, Giugliano D, Campanian Postprandial Hyperglycemia Study Group

It is now well established that when semaglutide is used to treat obesity, stopping the medication will lead to weight gain, usually back to the pretreat weight, so the effects of semaglutide are not everlasting, notes Dr

The empirical foundations of telemedicine interventions for chronic disease management

Common side effects include mild nausea, vomiting, and loose stools, typically emerging during dose escalation and resolving within weeks

Research shows that for every 1,000 people that are at risk of heart problems, if those people take a statin for three years, statins will prevent: 7 non-fatal heart attacks 4 strokes 2 deaths This means that nearly 99% of people will not benefit from statins, however, because 1% of people do benefit, this means that considering there are around 17.5 million people in the UK that are at risk of heart problems, thousands of heart attacks, strokes and death could be prevented